| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3852208 | American Journal of Kidney Diseases | 2007 | 8 Pages |
Abstract
Circulating levels of the cytokine visfatin/PBEF-1 are influenced by renal function, but are not associated with fat mass or surrogate markers of insulin resistance in patients with CKD. Visfatin was associated independently with level of sVCAM-1, a marker of endothelial damage.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Jonas MD, PhD, Anna MSc, Juan Jesús PharmD, Abdul R. MD, PhD, Mohamed E. MD, PhD, Olof MD, PhD, Peter MD, PhD, Bengt MD, PhD, Anders MD, PhD, Martin MD, PhD, Louise MSc, PhD, Peter MD, PhD,